Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ladarixin in Active Bullous Pemphigoid
NCT01571895Phase 2Terminated
- Sponsor
- Dompé
- Start
- Feb 2012
- Primary completion
- Jul 2012
- Modality
- Orthosteric Ligands
- Countries
- 2
01
Overview
A Phase 2 trial of ladarixin in Bullous Pemphigoid (BP), sponsored by Dompé. Started Feb 2012; status: terminated.
02
Drugs
ladarixin
03
Conditions
Bullous Pemphigoid (BP)
Beyond the preview
Go deeper on NCT01571895.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01571895.